Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten O Nielsen

Showing results (31-40 of 211) with videos related to

Pageof 22
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 26, 2022
Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial SarcomaAiniah Rushdiana Raquib, Jakob Hofvander, Monica Ta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 23, 2013
Reply to Y.Yamamoto et alAleix Prat, Miguel Martin, Torsten O Nielsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Ki67 as a Companion Diagnostic: Good or Bad News?Mitch Dowsett, Torsten O Nielsen, David L Rimm, et al.
Human Pathology|July 16, 2008
The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotypeDavid Voduc, Torsten O Nielsen, Maggie C Cheang, et al.
Clinical Breast Cancer|April 3, 2017
Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast CancerJudith-Anne W Chapman, Shuzhen Liu, Samuel Leung, et al.
Annual Review of Pathology|November 28, 2007
Gene expression profiling of breast cancerMaggie C U Cheang, Matt van de Rijn, Torsten O Nielsen
Oncoimmunology|November 1, 2018
TIM-3 expression in breast cancerSamantha Burugu, Dongxia Gao, Samuel Leung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2009
Expression of insulin-like growth factor 2 in mesenchymal neoplasmsSonja E Steigen, David F Schaeffer, Robert B West, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro modelsJefferson Terry, Joanna M Lubieniecka, Wanda Kwan, et al.
Molecular Cancer Therapeutics|June 21, 2008
Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma modelsShuzhen Liu, Hongwei Cheng, Wanda Kwan, et al.
Pageof 22

Showing results (31-40 of 211) with videos related to

Sort By:
Pageof 22
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 26, 2022
Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial SarcomaAiniah Rushdiana Raquib, Jakob Hofvander, Monica Ta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 23, 2013
Reply to Y.Yamamoto et alAleix Prat, Miguel Martin, Torsten O Nielsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2022
Ki67 as a Companion Diagnostic: Good or Bad News?Mitch Dowsett, Torsten O Nielsen, David L Rimm, et al.
Human Pathology|July 16, 2008
The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotypeDavid Voduc, Torsten O Nielsen, Maggie C Cheang, et al.
Clinical Breast Cancer|April 3, 2017
Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast CancerJudith-Anne W Chapman, Shuzhen Liu, Samuel Leung, et al.
Annual Review of Pathology|November 28, 2007
Gene expression profiling of breast cancerMaggie C U Cheang, Matt van de Rijn, Torsten O Nielsen
Oncoimmunology|November 1, 2018
TIM-3 expression in breast cancerSamantha Burugu, Dongxia Gao, Samuel Leung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 2, 2009
Expression of insulin-like growth factor 2 in mesenchymal neoplasmsSonja E Steigen, David F Schaeffer, Robert B West, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro modelsJefferson Terry, Joanna M Lubieniecka, Wanda Kwan, et al.
Molecular Cancer Therapeutics|June 21, 2008
Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma modelsShuzhen Liu, Hongwei Cheng, Wanda Kwan, et al.
Pageof 22